Clinical Trial Update: Risperidone and Suicidality in Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on risperidone for suicidality in major depressive disorder completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Depression | Phase 3 | Status: COMPLETED